[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Regenerative Medicine Market to Showcase Double-Digit Growth, According to Kelly Scientific Publications Report Available at MarketPublishers.c

16 May 2017 • by Natalie Aster

LONDON – As of 2016, the global market for regenerative medicine was worth just under USD 19 billion. It is set to grow at a double-digit rate of more than 23% in the coming years to eventually almost reach a value of USD 54 billion by 2021.

At present, there are more than 700 regenerative companies in the world, while the number of commercialized products is over 500.

Reconstructive surgeries for joints and bones form the mainstay of the global market for regenerative medicine. Geography-wise, the biggest chunk of the world’s marketplace belongs to the U.S. Europe is the number two player globally. In the meantime, the most rapid growth in the stem cell space is set to occur in Europe and Japan. So, Europe may dethrone the U.S. from the stem cell throne by 2021.

The regenerative medicine is set to have a large impact on the payers’ expenditure.

Huge sums of money have been poured into the generative medicine, cellular therapeutics, and gene therapy over the recent years. Sanofi, Eli Lilly, and BMS are some of these investors.

New research report “Global Regenerative Medicine Market Analysis & Forecast to 2021” elaborated by Kelly Scientific Publications offers an insightful guide to the global market for regenerative medicine. The study starts with a detailed introduction: it covers first trials, types of stem cells, and more.

It focuses on clinical trials for each type of stem cells. The report contains comprehensive case studies, and throws light on stem cell biomarkers. The research study explores the manufacturing process.

It examines investment and funding. The research report investigates the market performance in detail. The study also delves deep into the performance of all the segments of this space.

It profiles companies that lead the global race: MEDIPOST, Cynata Therapeutics, Mesoblast, NuVasive, and more. A SWOT industry analysis and future projections of the marketplace are on hand in the report, too.

More new research studies by our partner can be found at its page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest